Cephalalgia

Papers
(The TQCC of Cephalalgia is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Visual snow syndrome or “what's in a name?”104
Cutaneous allodynia in pediatric and adolescent patients and their mothers: A comparative study85
Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-ana70
Migraine and work – beyond absenteeism: Migraine severity and occupational burnout – A cohort study69
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine66
Glucocorticoid signaling mediates stress-induced migraine-like behaviors in a preclinical mouse model58
Characterizing opioid use in a Dutch cohort with migraine58
Latent class analysis of migraine associated vestibular-auditory symptoms57
Other primary headaches: Distinct clinical features and uncertain pathophysiology56
Abstracts of the 20th Biennial Migraine Trust International Symposium, London UK, 5th to 8th September 202450
Distinguishing persistent post-traumatic headache from migraine: Classification based on clinical symptoms and brain structural MRI data47
Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex46
The epidemiology of airplane headache: A cross-sectional study on point prevalence and characteristics in 50,000 travelers46
TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine42
Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks41
Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population41
Profile of Chinese Cluster Headache Register Individual Study (CHRIS): Clinical characteristics, diagnosis and treatment status data of 816 patients in China39
Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura38
Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model38
Harassment in the headache field: a global web-based cross-sectional survey35
Letter to the editor regarding “Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic34
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes33
Localized and widespread pressure pain hypersensitivity in patients with episodic or chronic migraine: A systematic review and meta-analysis31
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world31
CORRIGENDUM to ‘Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN’28
The molecular clock gene cryptochrome 1 (CRY1) and its role in cluster headache27
Comment on “Effect of COVID vaccination on monthly migraine days”27
Chronification of migraine sensitizes to CGRP in male and female mice27
Efficacy of ubrogepant and atogepant in males and females with migraine: A secondary analysis of randomized clinical trials27
The prevalence of headache disorders in children and adolescents in Iran: a schools-based study27
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models26
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports26
Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response26
COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection26
20th Congress of the International Headache Society September 8-12, 202125
Effects of cluster headache preventatives on mouse hypothalamic transcriptional homeostasis25
Epicranial headache part 1: Primary stabbing headache25
Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families25
The Jes Olesen awards for the advancement of headache medicine25
The prevalence and burden of medication overuse headache in Greece24
What do people want to know about “Growing Up with Migraine”? Results of a preference survey of people with lived experience to guide future research24
Cephalalgia: a legacy of excellence, a vision for tomorrow23
Building community and visibility: A year of social media growth for Cephalalgia23
Questionnaire and structural imaging data accurately predict headache improvement in patients with acute post-traumatic headache attributed to mild traumatic brain injury22
Indirect costs attributed to headache: A nation-wide survey of an active working population22
Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study22
Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients22
Late Breaking Author Index21
The impact of epigenetic mechanisms in migraine: Current knowledge and future directions21
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab21
The effect of low dose thyroid replacement therapy in patients with episodic migraine and subclinical hypothyroidism: A randomised placebo-controlled trial21
Development of a text message-based headache diary in adolescents and children20
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll20
The incremental burden and healthcare resource utilization among people with migraine in Europe: Insights from the 2020 European National Health and Wellness Survey20
Diagnostic utility of T2*-weighted GRE in migraine with aura attack. The cortical veins sign20
Treatment patterns and characteristics of headache in patients in Japan: A retrospective cross-sectional and longitudinal analysis of health insurance claims data19
The time sequence of brain MRI findings in spontaneous intracranial hypotension19
Grey matter structure within the visual networks in migraine with aura: multivariate and univariate analyses19
OnabotulinumtoxinA for primary new daily persistent headache and comparison to chronic migraine18
Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis18
International Classification of Headache Disorders-4 – Work in Progress 117
Systemic allergic reaction to galcanezumab (emgality): a case report17
Cumulative exposure to estrogen may increase the risk of migraine in women17
A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache17
Author Index16
Time and headache: Insights into timing processes in primary headache disorders for diagnosis, underlying pathophysiology and treatment implications16
A response: Update on cough, exertional and sex headache16
Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases16
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials15
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis15
CLOCK gene circannual expression in cluster headache15
High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients15
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-1915
Mesocorticolimbic system abnormalities in chronic cluster headache patients: A neural signature?15
No change in interictal plasma and salivary CGRP levels in individuals with vestibular migraine corresponding to episodic migraine15
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial15
CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine15
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review15
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care15
Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: A randomized controlled trial15
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?15
A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients14
Systemic lupus erythematosus mimicking retinal migraine: a case report14
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘14
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura14
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study14
Paroxysmal localized Hyperhidrosis, a case-report: When excessive sweating occurs in combination with severe headaches14
Identification and characterization of migraine in pregnancy: A Norwegian registry-based cohort study14
Primary headache disorders in Latin America and the Caribbean: A meta-analysis of population-based studies14
Altered interictal serum histamine and immunoglobulin E but unchanged tryptase levels in individuals with episodic and chronic migraine13
Headache characteristics and postoperative course in Chiari I malformation13
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study13
Targeting reactive nitroxidative species in preclinical models of migraine13
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies13
Depression screening in migraine - A double-edged sword13
Epicranial headaches part 2: Nummular headache and epicrania fugax13
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence13
DNA-methylation and immunological response in medication overuse headache13
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria13
Body mass index and migraine in adolescence: A nationwide study13
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex13
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study13
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data12
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study12
Mechanical sensitivity changes in pericranial muscles after local anesthesia and experimentally induced pain in the temporalis tendon: Implications for headache and facial pain12
Efficacy of surgical treatment in patients with trigeminal neuralgia secondary to multiple sclerosis: A prospective study of 18 cases with evaluation of outcome and complications by independent evalu12
What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry12
If headache has any association with hypertension, it is negative. Evidence from a population-based study in Nepal12
Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial12
Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review12
Time to retire ‘New daily persistent headache’: Mode of onset of chronic migraine and tension-type headache12
Association between headache frequency and risk for fibromyalgia in patients with migraine11
Corrigendum to: PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation11
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis11
Call for papers11
Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury11
Headaches and the use of personal protective equipment in the general population during the COVID-19 pandemic11
Headache in progressive facial hemiatrophy (Parry-Romberg syndrome): A paradigmatic case and systematic review of the literature10
Evaluation and treatment of headache associated with moyamoya disease – a narrative review10
Photophobia and allodynia in persistent post-traumatic headache are associated with higher disease burden10
The role of cytokines in migraine: A systematic review10
Methodological challenges in using screening tools for depression in migraine: A systematic review10
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury10
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa10
Prevalence and clinical features of hemicrania continua in clinic-based studies: A systematic review and meta-analysis10
Greater occipital nerve block in migraine may have a place in migraine treatment10
Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial10
Response to letter to the Editor: Assessing migraine therapeutics10
Co-morbidity between trigeminal autonomic cephalalgias and complex regional pain syndrome: Two case reports10
Intravenous fosphenytoin as treatment for acute exacerbation of trigeminal neuralgia: A prospective systematic study of 15 patients10
Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education in migraine treatment. A systematic review and meta-analysis10
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review10
The first prevalence study of primary headaches in adults in a post-conflict area of Serbia10
Personal view: Modelling pain mechanisms of migraine without aura10
Corrigendum to “Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials”9
Weight loss with atogepant during the preventive treatment of migraine: A pooled analysis9
Assessing migraine therapeutics9
Board Walk – April 20219
Lidocaine aerosol sprayed on oral and/or nasal mucosa for the rescue of acute trigeminal neuralgia exacerbations: A retrospective study9
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study9
Letter to the editor regarding “Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database”9
Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications9
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study9
Interim analysis of the Registry for Load and Management of Medication Overuse Headache (RELEASE): A multicenter, comprehensive medication overuse headache registry9
Pediatric screen exposure and school related headache disability9
New migraine drugs9
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers9
Effect of Altmetric score on manuscript citations: A randomized-controlled trial9
Response to letter to the editor: “What predicts citation counts and translational impact in headache research? A machine learning analysis”9
Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial9
Headache trajectories in children and adolescents with new onset continuous headache9
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”9
An altered reward system characterizes chronic migraine with medication overuse headache9
Telemedicine in headache care: A systematic review9
0.20185399055481